About Aparito
Aparito is a company based in London (United Kingdom) founded in 2015 was acquired by Lilly in July 2024. Aparito offers products and services including Atom5 eCOA Platform, Video Assessments, Wearables Integration, ePROs, and Telemedicine. Aparito operates in a competitive market with competitors including Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
- Headquarter London, United Kingdom
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aparito Limited
- Date of Incorporation 29 Oct, 2014
- Jurisdiction WREXHAM, WALES
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aparito
Aparito offers a comprehensive portfolio of products and services, including Atom5 eCOA Platform, Video Assessments, Wearables Integration, ePROs, and Telemedicine.
Platform for capturing and analyzing data in clinical trials via multiple devices
Enables video-based patient assessments for clinical trials
Integrates wearable devices for real-time health data collection
Facilitates electronic patient-reported outcomes in trials
Supports remote consultations and monitoring in clinical settings
Handles electronic consent processes for participants
People of Aparito
Unlock access to complete
Funding Insights of Aparito
Investors in Aparito
Aparito has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly and Bethnal Green Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are funded and accelerated through a venture program.
|
Locked | Locked | Locked | |
|
Traditional pharmaceutical medicines are developed for multiple health fields.
|
Locked | Locked | Locked |
Investor details for Aparito
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aparito
Investment portfolio details for Aparito
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aparito
Detailed financials for Aparito
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aparito Comparisons
Peer comparison for Aparito
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aparito
Aparito operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endotronix, Edwards Lifesciences, CoachCare, BioIntelliSense and Oxehealth, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Medical devices for structural heart disease are developed and provided.
|
|
| Locked | Locked | Locked |
Remote monitoring platform for tracking patient activity
|
|
| Locked | Locked | Locked |
Vital signs are monitored via a single-use patch and platform.
|
|
| Locked | Locked | Locked |
Contactless patient monitoring is provided for mental health facilities.
|
|
| Locked | Locked | Locked |
Provider of imaging technologies for medical diagnosis and treatments
|
Detailed competitors of Aparito
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aparito
Complete news archive for Aparito
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aparito
Aparito was founded in 2015.
Aparito is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Developer of a remote health monitoring tool for clinics. It develops a wearable device that has the ability to capture required health matrices and store them and sync them with the patients app when connected via Bluetooth. The patients app sends the data collected by the wearable device to the secure database after encrypting it. This data can be viewed on the web portal by authorized persons. App also allows patients to keep a track of medication, and clinical visits and record events like falls, seizures, and missed days of work.
Aparito's top competitors include Endotronix, TestCard and Oxehealth.
Aparito offers Atom5 eCOA Platform, Video Assessments, Wearables Integration, ePROs, and 2 more products and services.
Aparito has 2 investors. Key investors include Lilly, and Bethnal Green Ventures.